Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.

NCT04779047 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Pneumonia

Interventions

DRUG: Remdesivir
DRUG: Hydroxychloroquine
DRUG: Tocilizumab
DRUG: Lopinavir/ Ritonavir
DRUG: Ivermectin

Sponsor

October 6 University

Collaborators

[object Object]